User menu

Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.

Primary tabs
Add to cart
Print
Copyright (Sherpa/Romeo)
Authors :
Document type : Article de périodique (Journal article) – Journal Article
Abstract :

Due to the growing incidence and the severity of infections due to vancomycin resistant enterococci, it is now recommended to treat mild to moderate cases of Clostridium difficile-associated diarrhoea with metronidazole while maintaining the use of oral vancomycin in serious or life-threatening colitis. Clostridium difficile is a common cause of diarrhoea after antibiotic therapy and induces a spectrum of diseases ranging from mild diarrhoea to pseudomembranous colitis (PMC). It is considered to be the first cause of diarrhoea occurring among hospitalized patients (1).
Publication date : 1995
Journal information : "Acta clinica Belgica" - Vol. 50, no. 2, p. 114-6 (1995)
Peer reviewed : yes
issn : 0001-5512
Publication status : Publié
Affiliation : UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique
MESH Subject : Clostridium Infections - drug therapy ; Clostridium difficile ; Colitis - drug therapy - microbiology ; Humans ; Metronidazole - therapeutic use ; Vancomycin - therapeutic use
Links :
Bibliographic reference Delmée, Michel ; Melin, P. ; Peetermans, W. ; Verbist, L. ; Verschraegen, G.. Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.. In: Acta clinica Belgica, Vol. 50, no. 2, p. 114-6 (1995)
Permanent URL http://hdl.handle.net/2078.1/11863